Biogen Inc(NASDAQ:BIIB) 
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to ...
Website: http://www.biogen.com
Founded: 1978
Full Time Employees: 7,400
Sector: Healthcare
Industry: Drug Manufacturers-General
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 129.22
H 129.95
L 122.77
C 122.98
V 3,088,294
10EMA 122.98
20EMA 122.98
60EMA 122.98
120EMA 122.98
250EMA 122.98